Advances in the relationship between peritoneal microenvironment and peritoneal metastasis in colorectal cancer
-
摘要: 腹膜转移是结直肠癌(colorectal cancer,CRC)常见的转移方式之一,通常预示着患者不良的预后。腹膜衬贴于腹盆壁内面和腹盆腔各脏器的表面,具有丰富的血液供应和大量常驻和迁移到此处的特定类型的细胞。腹腔中的多种细胞成分,细胞外基质以及局部特殊的理化性质共同构成了一个复杂和相对稳定的腹腔微环境;多种细胞在此环境中可以被结直肠癌细胞所诱导,参与并为肿瘤的生长、侵袭和腹膜转移提供适宜的“土壤”。本文就这些腹腔中参与构成腹腔微环境的主要细胞成分进行综述。Abstract: Peritoneal metastasis is very common in colorectal cancer and often indicates bad prognosis.The peritoneum, which contains an abundant supply of blood and specific types of resident and migrating cells, lines the surface of the abdominal wall and coversthe abdominal organs.The combination of cells, extracellular matrix, and local unique physicochemical composition of the abdominalcavity provide a complex and relatively stable peritoneal microenvironment.The cells in this environment can be induced by cancercells to be involved in tumor growth, invasion, and peritoneal metastasis.This review summarizes the major cellular components involved in the peritoneal microenvironment.
-
Key words:
- colorectal cancer /
- peritoneal metastasis /
- peritoneal microenvironment /
- cells
-
[1] Van Gestel YR, de Hingh IH, van Herk-Sukel MP, et al.Patterns ofmetachronous metastases after curative treatment of colorectal cancer[J].Cancer Epidemiol, 2014, 38(4):448-454. doi: 10.1016/j.canep.2014.04.004 [2] Lv ZD, Wang HB, Dong Q, et al.Mesothelial cells differentiate intofibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo[J].Mol Cell Biochem, 2013, 377(1-2):177-185. doi: 10.1007/s11010-013-1583-0 [3] Mutsaers SE, Prêle MA, Pengelly S, et al.Mesothelial cells and peritoneal homeostasis[J].Fertil Steril, 2016, 106(5):1018-1024. doi: 10.1016/j.fertnstert.2016.09.005 [4] Hwang EH, Kim TH, Oh SM, et al.Toll/IL-1 domain-containing adaptor inducing IFN-beta(TRIF)mediates innate immune responses inmurine peritoneal mesothelial cells through TLR3 and TLR4 stimulation[J].Cytokine, 2016, 77(1):127-134. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480720/ [5] Shaw TJ, Zhang XY, Huo Z, et al.Human peritoneal mesothelial cellsdisplay phagocytic and antigen-presenting functions to contributeto intraperitoneal immunity[J].Int J Gynecol Cancer, 2016, 26(5):833-838. doi: 10.1097/IGC.0000000000000697 [6] Mikula-Pietrasik J, Sosinska P, Maksin K, et al.Colorectal cancerpromoting activity of the senescent peritoneal mesothelium[J].Oncotarget, 2015, 6(30):29178-29195. doi: 10.18632/oncotarget.v6i30 [7] Heath RM, Jayne DG, O'Leary R, et al.Tumour-induced apoptosis inhuman mesothelial cells: a mechanism of peritoneal invasion byFas Ligand/Fas interaction[J].Br J Cancer, 2004, 90(7):1437-1442. doi: 10.1038/sj.bjc.6601635 [8] Lee IK, Vansaun MN, Shim JH, et al.Increased metastases are associated with inflammation and matrix metalloproteinase-9 activityat incision sites in a murine model of peritoneal dissemination ofcolorectal cancer[J].J Surg Res, 2013, 180(2):252-259. doi: 10.1016/j.jss.2012.04.074 [9] Shen H, Ma JL, Zhang Y, et al.Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-kBsignaling in colorectal cancer cells[J].World J Gastroenterol, 2016, 21, 22(15):3969-3977. https://www.sciencedirect.com/science/article/pii/S0065128113002183 [10] Sandoval P, Jimenez-Heffernan JA, Rynne-Vidal A, et al.Carcinomaassociated fibroblasts derive from mesothelial cells via mesothelialto-mesenchymal transition in peritoneal metastasis[J].J Pathol, 2013, 231(4):517-531. doi: 10.1002/path.4281 [11] Ranieri D, Raffa S, Parente A, et al.High adhesion of tumor cells tomesothelial monolayers derived from peritoneal wash of disseminated gastrointestinal cancers[J].PLoS One, 2013, 8(2):e57659. https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3581532/ [12] Mikula-Pietrasik J, Uruski P, Matuszkiewicz K, et al.Ovarian cancerderived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells[J].Cell Oncol(Dordr), 2016, 39(5):473-481. doi: 10.1007/s13402-016-0289-1 [13] Ksiazek K, Mikula-Pietrasik J, Catar R, et al.Oxidative stress-dependent increase in ICAM-1 expression promotes adhesion of colorectal and pancreatic cancers to the senescent peritoneal mesothelium[J].Int J Cancer, 2010, 127(2):293-303. https://www.ncbi.nlm.nih.gov/pubmed/19904754 [14] Rynne-Vidal A, Jimenez-Heffernan JA, Fernandez-Chacon C, et al.The mesothelial origin of carcinoma associated-fibroblasts in peritoneal metastasis[J].Cancers(Basel), 2015, 7(4):1994-2011. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695872/ [15] Lin L, Liu A, Peng Z, et al.STAT3 is necessary for proliferation andsurvival in colon cancer-initiating cells[J].Cancer Res, 2011, 71(23):7226-7237. doi: 10.1158/0008-5472.CAN-10-4660 [16] Bai YP, Shang K, Chen H, et al.FGF-1/-3/FGFR4 signaling in cancerassociated fibroblasts promotes tumor progression in colon cancerthrough Erk and MMP-7[J].Cancer Sci, 2015, 106(10):1278-1287. doi: 10.1111/cas.12745 [17] Valenciano A, Henriquez-Hernandez LA, Moreno M, et al.Role of IGF-1 receptor in radiation response[J].Transl Oncol, 2012, 5(1):1-9. doi: 10.1593/tlo.11265 [18] Conti J, Thomas G.The role of tumourstroma in colorectal cancer invasion and metastasis[J].Cancers(Basel), 2011, 3(2):2160-2168 http://home.sandiego.edu/~josephprovost/Tumor%20Microenvironment.pdf [19] Schellerer VS, Langheinrich M, Hohenberger W, et al.Tumor-associated fibroblasts isolated from colorectal cancer tissues exhibit increased ICAM-1 expression and affinity for monocytes[J].OncolRep, 2014, 31(1):255-261. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369728/figure/F2/ [20] Pernot S, Terme M, Voron T, et al.Colorectal cancer and immunity:what we know and perspectives[J].World J Gastroenterol, 2014, 20(14):3738-3750. doi: 10.3748/wjg.v20.i14.3738 [21] Li T, Yi S, Liu W, et al.Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity[J].Med Oncol, 2013, 30(3):663. doi: 10.1007/s12032-013-0663-z [22] Goncalves-Ribeiro S, Guillen DN, Berdiel-Acer M, et al.Carcinomaassociated fibroblasts affect sensitivity to oxaliplatin and 5FU incolorectal cancer cells[J].Oncotarget, 2016, 7(37):59766-59780 doi: 10.18632/oncotarget.v7i37 [23] Nakanishi Y, Nakatsuji M, Seno H, et al.COX-2 inhibition alters thephenotype of tumor-associated macrophages from M2 to M1 inApcMin/+mouse polyps[J].Carcinogenesis, 2011, 32(9):1333-1339. doi: 10.1093/carcin/bgr128 [24] Gosselin D, Link VM, Romanoski CE, et al.Environment drives selection and function of enhancers controlling tissue-specific macrophage identitiess[J].Cell, 2014, 159(6):1327-1340. doi: 10.1016/j.cell.2014.11.023 [25] Marech I, Ammendola M, Sacco R, et al.Tumour-associated macrophages correlate with microvascular bed extension in colorectal cancerpatients[J].J Cell Mol Med, 2016, 20(7):1373-1380. doi: 10.1111/jcmm.2016.20.issue-7 [26] Barnett FH, Rosenfeld M, Wood M, et al.Macrophages form functional vascular mimicry channels in vivo[J].Sci Rep, 2016, 6:36659. doi: 10.1038/srep36659 [27] Weber CE, Kuo PC, The tumor microenvironment[J].Surg Oncol, 2012, 21(3):172-177. doi: 10.1016/j.suronc.2011.09.001 [28] Yu M, Niu ZM, Wei Y Q.Effective response of the peritoneum microenvironment to peritoneal and systemic metastasis from colorectal carcinoma[J].Asian Pac J Cancer Prev, 2013, 14(12):7289-7294. doi: 10.7314/APJCP.2013.14.12.7289 [29] Zhang Y, Sime W, Juhas M, et al.Crosstalk between colon cancer cellsand macrophages via inflammatory mediators and CD47 promotestumour cell migration[J].Eur J Cancer, 2013, 49(15):3320-3334. doi: 10.1016/j.ejca.2013.06.005 [30] Ugel S, Peranzoni E, Desantis G, et al.Immune tolerance to tumorantigens occurs in a specialized environment of the spleen[J].CellRep, 2012, 2(3):628-639. http://www.sciencedirect.com/science/article/pii/S2211124712002318 [31] Umansky V, Blattner C, Gebhardt C, et al.The role of myeloid-derivedsuppressor cells(MDSCs)in cancer progression[J].Vaccines(Basel), 2016, 4(4):10-13. https://www.nature.com/nrc/journal/v13/n10/nrc3581/metrics/news [32] Parker KH, Beury DW, Ostrand-Rosenberg S.Myeloid-derived suppressor cells: critical cells driving immune suppression in the tumor microenvi-ronment[J].Adv Cancer Res, 2015, 128(1):95-139. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697909/ [33] Blatner NR, Mulcahy MF, Dennis KL, et al.Expression of RORγtmarks a pathogenic regulatory T cell subset in human colon cancer[J].SciTransl Med, 2012, 4(164):159-164. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762575/figure/F8/ [34] Kryczek I, Wu K, Zhao E, et al.IL-17+regulatory T cells in the microenvironments of chronic inflammation and cancer[J].Immunol, 2011, 186(7):4388-4395. doi: 10.4049/jimmunol.1003251 [35] Jang TJ.Progressive increase of regulatory T cells and decrease of CD8+T cells and CD8+T cells/regulatory T cells ratio during colorectal cancerdevelopment[J].Korean J Pathol, 2013, 47(5):443-451. doi: 10.4132/KoreanJPathol.2013.47.5.443 [36] Gregor MF, Hotamsisligil GS.Inflammatory mechanisms in obesity[J].Annu Rev Immunol, 2011, 29(1):415-445. doi: 10.1146/annurev-immunol-031210-101322 [37] Vurusaner B, Poli G, Basaga H.Tumor suppressor genes and ROS:complex networks of interactions[J].Free RadicBiol Med, 2012, 52(1):7-18. doi: 10.1016/j.freeradbiomed.2011.09.035 [38] Coelho P, Almeida J, Prudencio C, et al.Effect of Adipocyte Secretome in Melanoma Progression and VasculogenicMimicry[J].J CellBiochem, 2016, 117(7):1697-1706. doi: 10.1056/NEJMra0805239?query=recent&rss=1 [39] Del CM, D'Archivio M, Conti L, et al.Visceral fat adipocytes fromobese and colorectal cancer subjects exhibit distinct secretory andω6 polyunsaturated fatty acid profiles and deliver immunosuppressive signals to innate immunity cells[J].Oncotarget, 2016, 7(39):63093-63105. doi: 10.18632/oncotarget.v7i39
点击查看大图
计量
- 文章访问数: 75
- HTML全文浏览量: 10
- PDF下载量: 13
- 被引次数: 0